METHOD FOR CULTURING ALLOGENEIC IMMUNE CELL, IMMUNE CELL CULTURE OBTAINED THEREBY, AND IMMUNE CELL THERAPEUTIC AGENT COMPRISING SAME
A method of culturing an allogeneic immune cell according to an embodiment of the present disclosure efficiently amplifies and activates natural killer cells (NK cells), which are effective in treating malignant tumors, by culturing lymphocytes derived from the blood of healthy donors rather than patients to whom an immune cell therapeutic agent is to be administered..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Europäisches Patentamt - (2022) vom: 02. Juni Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
SHIN JI SEOP [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-06-02, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09 |
|---|
| Patentnummer: |
US2022168348 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003004597 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003004597 | ||
| 003 | DE-627 | ||
| 005 | 20240409142721.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240409s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA003004597 | ||
| 035 | |a (EPA)US2022168348 | ||
| 035 | |a (EPA)72426421 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a SHIN JI SEOP |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a METHOD FOR CULTURING ALLOGENEIC IMMUNE CELL, IMMUNE CELL CULTURE OBTAINED THEREBY, AND IMMUNE CELL THERAPEUTIC AGENT COMPRISING SAME |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2022-06-02, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09 | ||
| 520 | |a A method of culturing an allogeneic immune cell according to an embodiment of the present disclosure efficiently amplifies and activates natural killer cells (NK cells), which are effective in treating malignant tumors, by culturing lymphocytes derived from the blood of healthy donors rather than patients to whom an immune cell therapeutic agent is to be administered. | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61Q: Specific use of cosmetics or similar toilet preparations | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a SHIN WOO SEOP |e verfasserin |4 aut | |
| 700 | 0 | |a JANG MIN JI |e verfasserin |4 aut | |
| 700 | 0 | |a SHIN DONG HYUK |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 02. Juni |
| 773 | 1 | 8 | |g year:2022 |g day:02 |g month:06 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/72426421/publication/US2022168348A1?q=US2022168348 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 02 |c 06 | ||